- Home
- Trader’s Dashboard
- Technical Analysis
- Screener
- Tools Library
- Advanced Currency Converter
- Economic Calendar
- Central Bank Rates
- Dividend Adjustment
- CFD Adjustment
- National Holidays
- Trading Breaks
- Sentiment
- Broker Spread
- Intraday Movers & Shakers
- Pivot Points Calendar
- Market Summary
- Historical Data Export
- Spread
- Technical Indicators
- Market Signals
- Market Hours
- Profit Calculator
- Margin Requirements
- Overnight Swaps
- Live Quotes
- Forex News
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: FX
US still working on trade deals despite court ruling, USTR says Source link
Australia’s July CPI report delivered a substantial upside surprise, printing at 2.8% annually versus 2.0% expected. This hot inflation reading temporarily reduced RBA easing expectations and provided support for the Australian dollar during a week dominated by Fed independence concerns and mixed risk sentiment. Let’s examine which pairs from our watchlist capitalized on this environment of reduced RBA dovishness and broad USD weakness to determine if our bullish AUD bias delivered profitable opportunities. Watchlists are price outlook & strategy discussions supported by both fundamental & technical analysis, a crucial step towards creating a high quality discretionary trade idea before working…
Mon: US Labor Day, South Korean Trade Balance Prelim (Aug), Chinese Caixin Manufacturing PMI (Final), EZ, UK, US Manufacturing PMI (Final), New Zealand Terms of Trade (Q2)Tue: South Korean CPI (Aug), EZ Flash HICP (Aug), US ISM Manufacturing PMI (Aug)Wed: NBP Announcement, Australia Real GDP (Q2), US ADP National Employment (Aug), Chinese Caixin Services PMI (Final), EZ, UK, US Services PMI (Final), US Durable Goods R (Jul)Thu: Swedish CPIF (Aug), US ISM Services PMI (Aug)Fri: UK Retail Sales (Aug), EZ GDP R (Q2), US Jobs Report (Aug), Canadian Jobs Report (Aug)EZ Flash HICP (Tue): Expectations are for HICP Flash Y/Y…
The problem becomes even more serious when price suddenly shifts direction. A trader might jump in too early or exit too late, only to watch the market move against them. Relying on a single indicator or gut feeling doesn’t always work, especially in volatile markets. What traders need is a tool that not only follows the trend but also shows them important price zones where big moves are likely to happen. Brooky Psar Levels MT4 Indicator This is where the Brooky Psar Levels MT4 Indicator steps in. It builds upon the traditional Parabolic SAR system but makes it far more…
Australia government condemns anti-immigration rally in Sydney Source link
These Chinese PMIs come from the National Bureau of Statistics (NBS) and the China Federation of Logistics and Purchasing (CFLP).For August 2025:Manufacturing PMI 49.4, a slight missexpected 49.5, prior 49.3this is the fifth consecutive month in contraction for the official manufacturing PMIdomestic demand remains disappointing, weighed down by factors such asthe heavily indebted property sector and falling or, at best, flat prices for homesUS tariffs hitting exportslocal government debt recent extreme weather/floodingNon-Manufacturing (includes services and construction) PMI 50.3, in line with central estimates and a jump from Julyexpected 50.3, prior 50.1Composite 50.5—Over the next few days we’ll get the ‘unofficial’…
The Money Management Visualizer MT4 Indicator is built to make trading safer and more structured. Instead of guessing lot sizes, it calculates the appropriate position based on account balance, risk percentage, and stop-loss levels. This helps traders avoid overexposure and ensures they never risk more than they can afford. The indicator gives a visual representation of risk, so traders can see exactly how much they’re putting on the line before placing a trade. Why Money Management Matters Many traders focus only on entry and exit signals, forgetting that money management plays a bigger role in long-term success. Without proper risk…
Tennis-Ostapenko apologises for 'no education' comments made to Townsend Source link
HJBC/iStock Editorial via Getty Images The U.S. Food and Drug Administration (FDA) has approved Wayrilz, a Bruton’s tyrosine kinase (BTK) inhibitor developed by Sanofi (NASDAQ:SNY), as a treatment for a bleeding disorder known as immune thrombocytopenia (ITP). Accordingly, the oral treatment currently under review for ITP Source link
Senator Sanders says U.S. Health Secretary Kennedy must resign Source link
